Share:
Peer-Reviewed Publication
Chest2026;169(6):1676-1688.June 1, 2026Journal Article

Impact of Positive Airway Pressure Therapy on Health Care Resource Use in Patients With OSA and Coronary Artery Disease.

Peter A Cistulli1, Anita S Malik2, Adam V Benjafield3, Naomi Alpert2, Caleb Woodford4, Jean-Louis Pepin5, Kimberly L Sterling2, Kate V Cole2, Atul Malhotra6, Ann Cameron2, Gemma Figtree7,
1Charles Perkins Centre, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: Peter.cistulli@sydney.edu.au.
2ResMed Science Center, San Diego, CA.
3ResMed Science Center, Sydney, NSW, Australia.
4ResMed Science Centre, Halifax, NS, Canada.
5HP2 Laboratory, Institut National de la Sante et de la Recherche Medicale, Grenoble Alpes University, Grenoble, France.
6University of California, San Diego, La Jolla, CA.
7Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia; Cardiovascular Discovery Group, Kolling Institute of Medical Research, Sydney, NSW, Australia.

Abstract

BACKGROUND: OSA is associated with coronary artery disease (CAD) risk. This study examined the impact of positive airway pressure (PAP) therapy adherence on health care resource use (HCRU) in patients with CAD and newly diagnosed OSA. RESEARCH QUESTION: Is adherence to PAP therapy associated with reduced HCRU in patients with CAD and OSA? STUDY DESIGN AND METHODS: This retrospective analysis lin…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.